Dr. Eric A. Secemsky, of Beth Israel Lahey Health, Boston, discusses with Dr. Ron Waksman initial results from the SAFE-PAD study, which was presented as a late-breaking trial at ACC.21 Virtual. The observational study found that among more than 160,000 Medicare beneficiaries, in the treatment of peripheral artery disease, paclitaxel-coated devices were non-inferior to non-drug-coated devices with respect to mortality.